World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
71532
World Ranking
2377
National Ranking
1340

Hillard M. Lazarus publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hillard M. Lazarus sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,093 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hillard M. Lazarus D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hillard M. Lazarus sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 131 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hillard M. Lazarus is affiliated with Case Western Reserve University in the United States. The scientist's research portfolio includes over 500 publications primarily within the field of medicine, with significant work in hematology, oncology, genetics, public health, environmental and occupational health, and immunology.

Their research addresses a wide range of topics related to blood cancers and transplantation. Key areas of focus include hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, chronic myeloid leukemia treatments, multiple myeloma research and treatments, CAR-T cell therapy research, and quality of life for childhood cancer survivors.

Notable recent papers authored or coauthored by the scientist cover various critical topics:

  • Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis, 2021, Blood
  • Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults, 2024, New England Journal of Medicine
  • Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved, 2020, Blood Reviews
  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL, 2021, Blood
  • Survival following allogeneic transplant in patients with myelofibrosis, 2020, Blood Advances

Frequent coauthors collaborating with Hillard M. Lazarus include:

  • Mark R. Litzow
  • Miguel Ángel Díaz
  • Robert Peter Gale
  • Taiga Nishihori
  • Siddhartha Ganguly

The scientist has published extensively in several leading journals, contributing notably to:

  • Blood (28 publications)
  • Transplantation and Cellular Therapy (28 publications)
  • UNC Libraries (19 publications)
  • Bone Marrow Transplantation (18 publications)
  • Blood Reviews (14 publications)

Hillard M. Lazarus' work is interdisciplinary within the biomedical sciences, reflecting a substantial engagement with hematologic malignancies and transplantation immunology, intersecting clinical and translational research domains. The publication record indicates ongoing contributions to evolving therapies for leukemia and related conditions, highlighting the scientist's involvement in both clinical trial reporting and molecular classification studies.

Best Publications

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy

    Omer N. Koç;Stanton L. Gerson;Brenda W. Cooper;Stephanie M. Dyhouse

  • Outcomes after transplantation of cord Blood or bone marrow from unrelated donors in adults with leukemia

    Mary J. Laughlin;Mary Eapen;Pablo Rubinstein;John E. Wagner

  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

    Thomas J. Walsh;Peter Pappas;Drew J. Winston;Hillard M. Lazarus

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

    Hillard M. Lazarus;Omer N. Koc;Steven M. Devine;Peter Curtin

  • Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors

    Mary J. Laughlin;Juliet Barker;Barbara Bambach;Omer N. Koc

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

    Hillard M Lazarus;Stephen E Haynesworth;Stanton L Gerson;N. S. Rosenthal

  • Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Adele K. Fielding;Susan M. Richards;Rajesh Chopra;Hillard M. Lazarus

  • Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

    O. N. Koç;J. Day;M. Nieder;Stanton L Gerson

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

    Peter A. Cassileth;David P. Harrington;Frederick R. Appelbaum;Hillard M. Lazarus

  • Detection and Viability of Tumor Cells in Peripheral Blood Stem Cell Collections From Breast Cancer Patients Using Immunocytochemical and Clonogenic Assay Techniques

    Amy A. Ross;Brenda W. Cooper;Hillard M. Lazarus;Wilma Mackay

  • Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321

    Bart Barlogie;Robert A. Kyle;Kenneth C. Anderson;Philip R. Greipp

  • Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

    Edward A. Stadtmauer;Anne O'Neill;Lori J. Goldstein;Pamela A. Crilley

  • Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome

    Brian L. McClune;Daniel J. Weisdorf;Tanya L. Pedersen;Gisela Tunes da Silva

  • Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

    Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine

Frequent Co-Authors

Mark R. Litzow
Mark R. Litzow Mayo Clinic
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Parameswaran Hari
Parameswaran Hari Medical College of Wisconsin
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Marcos de Lima
Marcos de Lima The Ohio State University
David I. Marks
David I. Marks University Hospitals Bristol NHS Foundation Trust
Navneet S. Majhail
Navneet S. Majhail Cleveland Clinic
Stanton L. Gerson
Stanton L. Gerson Case Western Reserve University
Martin S. Tallman
Martin S. Tallman Northwestern University
Richard T. Maziarz
Richard T. Maziarz Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in diverse healthcare careers beyond a traditional MD, there are many flexible online degrees available. Programs such as the easiest dnp program online make it possible for nurses to earn a Doctor of Nursing Practice credential with less disruption to their current work schedules. These advanced degrees can open doors to leadership or specialized nursing roles.

If you’re looking to enter the healthcare workforce quickly, consider the fastest lpn program options available online. Licensed Practical Nurse (LPN) programs offer a practical, rapid route to hands-on patient care. For those interested in mental health, psych np programs provide specialized training for aspiring Psychiatric Mental Health Nurse Practitioners.

Not all healthcare roles are clinical. If you prefer the business side of healthcare, an online health management degree is ideal. These programs build essential skills in administration and policy, preparing you for impactful roles in hospitals and health organizations.

Best Scientists Citing Hillard M. Lazarus

Trending Scientists

Recently Published Articles